Prestige Consumer Healthcare Inc. (PBH) Financial Statements (2023 and earlier)
Company Profile
Business Address |
660 WHITE PLAINS RD. TARRYTOWN, NY 10591 |
State of Incorp. | |
Fiscal Year End | March 31 |
Industry (SIC) | 2834 - Pharmaceutical Preparations (benchmarking) |
More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in millions)Annual | Quarterly
3/31/2022 | 12/31/2021 TTM | 3/31/2021 | 3/31/2020 | 3/31/2019 | 3/31/2018 | 3/31/2017 | |||
---|---|---|---|---|---|---|---|---|---|
ASSETS | |||||||||
Current Assets | |||||||||
Cash, cash equivalents, and short-term investments | 27 | 21 | 32 | 95 | 28 | 33 | 42 | ||
Cash and cash equivalents | 27 | 21 | 32 | 95 | 28 | 33 | 42 | ||
Receivables | 139 | 134 | 115 | 151 | 149 | 141 | 137 | ||
Inventory, net of allowances, customer advances and progress billings | 120 | 106 | 115 | 116 | 120 | 119 | 116 | ||
Inventory | 120 | 106 | 115 | 116 | 120 | 119 | 116 | ||
Other undisclosed current assets | 6 | 14 | 8 | 4 | 5 | 12 | 40 | ||
Total current assets: | 293 | 275 | 270 | 366 | 301 | 303 | 334 | ||
Noncurrent Assets | |||||||||
Finance lease, right-of-use asset | 7 | 7 | 9 | 6 | ✕ | ✕ | ✕ | ||
Operating lease, right-of-use asset | 20 | 22 | 24 | 29 | ✕ | ✕ | ✕ | ||
Property, plant and equipment | 71 | 70 | 70 | 56 | 51 | 53 | 51 | ||
Intangible assets, net (including goodwill) | 3,276 | 3,283 | 3,054 | 3,055 | 3,086 | 3,401 | 3,519 | ||
Goodwill | 579 | 579 | 578 | 575 | 579 | 620 | 615 | ||
Intangible assets, net (excluding goodwill) | 2,697 | 2,704 | 2,476 | 2,479 | 2,507 | 2,781 | 2,904 | ||
Other noncurrent assets | 3 | 3 | 3 | 3 | 3 | 4 | 7 | ||
Total noncurrent assets: | 3,377 | 3,384 | 3,159 | 3,148 | 3,140 | 3,457 | 3,577 | ||
TOTAL ASSETS: | 3,671 | 3,659 | 3,429 | 3,514 | 3,441 | 3,761 | 3,911 | ||
LIABILITIES AND EQUITY | |||||||||
Liabilities | |||||||||
Current Liabilities | |||||||||
Accounts payable and accrued liabilities | 131 | 123 | 108 | 136 | 120 | 116 | 138 | ||
Accounts payable | 56 | 40 | 46 | 62 | 57 | 61 | 70 | ||
Accrued liabilities | 48 | 52 | 40 | 47 | 43 | 32 | 40 | ||
Employee-related liabilities | 20 | 15 | 14 | 13 | 11 | 11 | 16 | ||
Taxes payable | 3 | 0 | 2 | 3 | 0 | 2 | 4 | ||
Interest and dividends payable | 4 | 15 | 6 | 10 | 10 | 10 | 8 | ||
Debt | 3 | 3 | 3 | 7 | |||||
Other undisclosed current liabilities | 10 | 10 | 11 | 8 | 7 | 7 | 24 | ||
Total current liabilities: | 143 | 135 | 122 | 150 | 127 | 123 | 162 | ||
Noncurrent Liabilities | |||||||||
Long-term debt and lease obligation | 1,497 | 1,572 | 1,506 | 1,760 | 1,799 | 1,993 | 2,194 | ||
Long-term debt, excluding current maturities | 1,477 | 1,550 | 1,480 | 1,730 | 1,799 | 1,993 | 2,194 | ||
Finance lease, liability | 5 | 5 | 7 | 5 | ✕ | ✕ | ✕ | ||
Operating lease, liability | 16 | 18 | 20 | 25 | ✕ | ✕ | ✕ | ||
Liabilities, other than long-term debt | 452 | 453 | 443 | 433 | 29 | 34 | 18 | ||
Deferred income tax liabilities | 445 | 445 | 434 | 408 | ✕ | ✕ | ✕ | ||
Liability, pension and other postretirement and postemployment benefits | 9 | 11 | |||||||
Other liabilities | 7 | 8 | 9 | 25 | 20 | 23 | 18 | ||
Other undisclosed noncurrent liabilities | (20) | 391 | 432 | 715 | |||||
Total noncurrent liabilities: | 1,950 | 2,006 | 1,949 | 2,193 | 2,218 | 2,459 | 2,927 | ||
Total liabilities: | 2,093 | 2,141 | 2,071 | 2,343 | 2,345 | 2,582 | 3,089 | ||
Stockholders' equity | |||||||||
Stockholders' equity attributable to parent | 1,578 | 1,518 | 1,358 | 1,171 | 1,096 | 1,179 | 823 | ||
Common stock | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||
Treasury stock, value | (134) | (134) | (131) | (118) | (60) | (8) | (7) | ||
Additional paid in capital | 516 | 513 | 500 | 488 | 479 | 469 | 458 | ||
Accumulated other comprehensive loss | (19) | (23) | (20) | (44) | (26) | (19) | (26) | ||
Retained earnings | 1,214 | 1,162 | 1,009 | 844 | 702 | 736 | 397 | ||
Total stockholders' equity: | 1,578 | 1,518 | 1,358 | 1,171 | 1,096 | 1,179 | 823 | ||
TOTAL LIABILITIES AND EQUITY: | 3,671 | 3,659 | 3,429 | 3,514 | 3,441 | 3,761 | 3,911 |
Income Statement (P&L) ($ in millions) Annual | Quarterly
3/31/2022 | 12/31/2021 TTM | 3/31/2021 | 3/31/2020 | 3/31/2019 | 3/31/2018 | 3/31/2017 | ||
---|---|---|---|---|---|---|---|---|
Revenues | 1,087 | 1,051 | 943 | 963 | 976 | 1,041 | 882 | |
Revenue, net | ✕ | ✕ | ✕ | ✕ | ✕ | 1,041 | 882 | |
Cost of revenue | (466) | (441) | (396) | (411) | (420) | (465) | (46) | |
Cost of goods and services sold | (7) | (9) | (6) | (4) | (5) | (5) | (46) | |
Other undisclosed gross profit | (336) | |||||||
Gross profit: | 621 | 611 | 547 | 552 | 556 | 577 | 500 | |
Operating expenses | (291) | (278) | (250) | (261) | (488) | (361) | (295) | |
Operating income: | 330 | 333 | 297 | 291 | 68 | 216 | 206 | |
Nonoperating income (expense) | (1) | 1 | 1 | (1) | (0) | 0 | 0 | |
Investment income, nonoperating | 0 | 0 | 0 | 0 | ||||
Other nonoperating income (expense) | (1) | (1) | 1 | (2) | (0) | |||
Interest and debt expense | (66) | (21) | (95) | (99) | (105) | (109) | (95) | |
Income (loss) from continuing operations before income taxes: | 262 | 313 | 204 | 191 | (38) | 107 | 111 | |
Income tax expense (benefit) | (57) | (52) | (39) | (49) | 2 | 232 | (41) | |
Net income (loss): | 205 | 261 | 165 | 142 | (36) | 340 | 69 | |
Other undisclosed net loss attributable to parent | (48) | |||||||
Net income (loss) available to common stockholders, diluted: | 205 | 213 | 165 | 142 | (36) | 340 | 69 |
Comprehensive Income ($ in millions)Annual | Quarterly
3/31/2022 | 12/31/2021 TTM | 3/31/2021 | 3/31/2020 | 3/31/2019 | 3/31/2018 | 3/31/2017 | ||
---|---|---|---|---|---|---|---|---|
Net income (loss): | 205 | 261 | 165 | 142 | (36) | 340 | 69 | |
Other comprehensive income | 0 | 0 | 0 | |||||
Other undisclosed comprehensive income | 0 | |||||||
Comprehensive income (loss): | 206 | 261 | 165 | 142 | (36) | 340 | 69 | |
Other undisclosed comprehensive income (loss), net of tax, attributable to parent | 0 | (27) | 24 | (18) | (6) | 7 | (3) | |
Comprehensive income (loss), net of tax, attributable to parent: | 206 | 234 | 189 | 124 | (42) | 347 | 67 |
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.